SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-17-005551
Filing Date
2017-09-07
Accepted
2017-09-07 18:56:38
Documents
1
Period of Report
2017-09-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-39597.html 4  
1 PRIMARY DOCUMENT marketforms-39597.xml 4 3523
  Complete submission text file 0001214659-17-005551.txt   4917
Mailing Address PENINSULA PHARMACEUTICALS, INC. 1751 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address
TRUEX PAUL F (Reporting) CIK: 0001120362 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34637 | Film No.: 171074859

Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations